290 related articles for article (PubMed ID: 9187126)
1. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker C; Millar DS; Paul CL; Warnecke PM; Harrison J; Vincent PC; Frommer M; Clark SJ
Cancer Res; 1997 Jun; 57(11):2229-37. PubMed ID: 9187126
[TBL] [Abstract][Full Text] [Related]
2. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
[TBL] [Abstract][Full Text] [Related]
3. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site.
Ouellette MM; Chen J; Wright WE; Shay JW
Oncogene; 1992 Jun; 7(6):1075-81. PubMed ID: 1534398
[TBL] [Abstract][Full Text] [Related]
4. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
Melki JR; Vincent PC; Clark SJ
Cancer Res; 1999 Aug; 59(15):3730-40. PubMed ID: 10446989
[TBL] [Abstract][Full Text] [Related]
5. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
Millar DS; Ow KK; Paul CL; Russell PJ; Molloy PL; Clark SJ
Oncogene; 1999 Feb; 18(6):1313-24. PubMed ID: 10022813
[TBL] [Abstract][Full Text] [Related]
6. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene.
Ohtani-Fujita N; Fujita T; Aoike A; Osifchin NE; Robbins PD; Sakai T
Oncogene; 1993 Apr; 8(4):1063-7. PubMed ID: 8455933
[TBL] [Abstract][Full Text] [Related]
7. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
8. High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
Wilcox CB; Baysal BE; Gallion HH; Strange MA; DeLoia JA
Cancer Genet Cytogenet; 2005 Jun; 159(2):114-22. PubMed ID: 15899382
[TBL] [Abstract][Full Text] [Related]
9. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
10. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
13. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
McCabe MT; Davis JN; Day ML
Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
[TBL] [Abstract][Full Text] [Related]
14. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2).
Di Fiore B; Palena A; Felsani A; Palitti F; Caruso M; Lavia P
Nucleic Acids Res; 1999 Jul; 27(14):2852-9. PubMed ID: 10390525
[TBL] [Abstract][Full Text] [Related]
15. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
Inoue S; Oishi M
Gene; 2005 Mar; 348():123-34. PubMed ID: 15777718
[TBL] [Abstract][Full Text] [Related]
16. Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.
Gebhard C; Schwarzfischer L; Pham TH; Andreesen R; Mackensen A; Rehli M
Nucleic Acids Res; 2006 Jul; 34(11):e82. PubMed ID: 16822855
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors.
Picon A; Bertagna X; de Keyzer Y
Oncogene; 1999 Apr; 18(16):2627-33. PubMed ID: 10353606
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
19. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]